Synbio Tech Inc. (TPEX:1295)

Synbio Tech Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	155.61	170.13	113.27	92.52
Depreciation & Amortization	73.91	76.04	76.88	77.27
Loss (Gain) From Sale of Assets	0.45	-	0.06	-
Provision & Write-off of Bad Debts	0.14	-	-	0.33
Other Operating Activities	-14.82	12.83	19.3	1.02
Change in Accounts Receivable	23.09	-5.01	-27.04	25.21
Change in Inventory	-91.3	-13.97	7.11	0.59
Change in Accounts Payable	-1.49	5.77	7.99	-9.93
Change in Unearned Revenue	1.5	-5.8	8.52	-0.21
Change in Other Net Operating Assets	16.49	21.55	7.85	0.29
Operating Cash Flow	167.03	261.54	213.93	187.09
Operating Cash Flow Growth	-36.68%	22.25%	14.35%	-
Capital Expenditures	-528.72	-302.15	-327.29	-216.63
Sale of Property, Plant & Equipment	0.09	-	0.02	-
Sale (Purchase) of Intangibles	-1.77	-8.8	-0.41	-3.64
Investment in Securities	-105.86	-1.81	190.17	16.87
Other Investing Activities	0.54	-0.45	0.35	-0.03
Investing Cash Flow	-635.73	-313.21	-137.17	-203.43
Long-Term Debt Issued	-	240.63	301.02	267.22
Short-Term Debt Repaid	-	-	-72.5	-107.72
Long-Term Debt Repaid	-	-28.49	-117.87	-29.55
Total Debt Repaid	-171.34	-28.49	-190.37	-137.27
Net Debt Issued (Repaid)	309.39	212.14	110.64	129.95
Common Dividends Paid	-109.74	-46.11	-61.48	-70.15
Financing Cash Flow	378.87	166.03	49.16	59.8
Foreign Exchange Rate Adjustments	0.28	8.29	-5.47	-1.78
Net Cash Flow	-89.54	122.65	120.46	41.68
Free Cash Flow	-361.68	-40.62	-113.36	-29.54
Free Cash Flow Margin	-36.15%	-4.11%	-13.77%	-4.00%
Free Cash Flow Per Share	-11.09	-1.29	-3.60	-0.94
Cash Interest Paid	10.85	8.27	7.3	4.83
Cash Income Tax Paid	44.68	42.75	18.41	27.27
Levered Free Cash Flow	-422.34	-61.86	37.91	-
Unlevered Free Cash Flow	-417.95	-59.54	42.04	-
Change in Working Capital	-51.71	2.54	4.43	15.95

Source: S&P Global Market Intelligence. Standard template. Financial Sources.